Potential treatment
[용어속성] Term
Cell‐based therapy to reduce mortality from COVID ‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome
Concise Review
[키워드] acute respiratory distress
acute respiratory distress syndrome
adipose
Administered
adverse event
Allogeneic
alveolar
ARDS
Bone marrow
Cell therapy
clinical
clinical study
Combined
comparison
contribute
COVID
COVID‐19
COVID‐19 infection
COVID‐19
cytokine
cytokine production
death
determine
edema
Inflammatory
inflammatory biomarker levels
Injury
intravenously
literature review
Lung compliance
Macrophage
membrane
menstrual blood
Mesenchymal stromal cells
Mild
modulate
Mortality
MSC
MSC therapy
MSCs
nine
PaO
Participants
patients with ARDS
performed
Potential treatment
Pulmonary function
Radiographic
reduce mortality
reduction
remodeling processe
reported
resolved
Serious Adverse Event
shown
statistical significance
stromal cell
syndrome
systematic review
T‐cell
therapy
tissue
Trial
umbilical
variant
yielding
[DOI] 10.1002/sctm.20-0146 PMC 바로가기 [Article Type] Concise Review
[DOI] 10.1002/sctm.20-0146 PMC 바로가기 [Article Type] Concise Review
Intravenous infusion of human umbilical cord Wharton’s jelly-derived mesenchymal stem cells as a potential treatment for patients with COVID-19 pneumonia
Case Reports
[키워드] C-reactive protein
CD3
CD4
CD8
China
COVID-19
COVID-19 pathogenesis
discharged
drug
effective
global public health
healthy donor
highlight
Human umbilical cord Wharton’s jelly-derived MSCs
IL-6
immune system
immunomodulatory
Infection
Inflammation
intravenous
intravenous infusion
Liaocheng
Lymphocyte subset
mesenchymal stem cell
MSC
MSCs
novel coronavirus disease
Patient
patients with COVID-19
Pneumonia
Potential treatment
Pulmonary function
Safe
severe COVID-19
shown
significantly
stem cell
Symptom
T cell
the patient
TNF-α
treated
Treatment
treatment for COVID-19
umbilical
Vaccine
Wharton’s jelly-derived MSC
with COVID-19
Wuhan, China
[DOI] 10.1186/s13287-020-01725-4 PMC 바로가기 [Article Type] Case Reports
[DOI] 10.1186/s13287-020-01725-4 PMC 바로가기 [Article Type] Case Reports
Review of trials currently testing treatment and prevention of COVID-19
Systematic Review
Published on
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 신약개발, 임상, 치료법,
Journal: Clinical microbiology and infection : the official [Category] MERS, SARS, 신약개발, 임상, 치료법,
[키워드] Abstract
age
analysed
Anti-inflammatory
antivirals
applied
assist
category
Chinese
clinical
clinical trial
clinical trials
country
COVID-19
COVID-19 case
COVID-19 pandemic
effort
eligibility criteria
European
evaluated
Evidence
excluded
Image
immunomodulators
Inclusion
interquartile range
Intervention
investigated
Major
management
median
Novel coronavirus
Numerous
objective
open label
participant
Patient care
performed
physician
Pneumonia
Potential treatment
prevention
prevention of COVID-19
promote
Randomized
Randomized controlled trial
Registered
registry
Research
researcher
Result
retrieved
review
SARS-CoV-2
searched
Study design
therapeutic
Treatment
Trial
union
withdrawn
[DOI] 10.1016/j.cmi.2020.05.019 PMC 바로가기 [Article Type] Systematic Review
[DOI] 10.1016/j.cmi.2020.05.019 PMC 바로가기 [Article Type] Systematic Review
The Lung, the Heart, the Novel Coronavirus, and the Renin-Angiotensin System; The Need for Clinical Trials
Medicine
[키워드] ACE2
ACEIs
Acute cardiac injury
acute lung injury
acute respiratory distress
angiotensin
Angiotensin II
angiotensin-converting enzyme inhibitor
ARB
ARBs
ARDS
Arrhythmias
benefit
bind
blockers
cardiovascular disease
caused
clinical
COVID-19
COVID-19 patient
drug
enzyme
heart
heart failure
Hospitalization
Inflammatory
inflammatory effect
kidney
lung
Lung injury
myocarditis
novel
Other
Potential treatment
Prevent
PROTECT
Protective
receptor
renin-angiotensin system (RAS)
risk
SARS- CoV-2
SARS-CoV
SARS-CoV-2
suppresse
syndrome
Trial
[DOI] 10.3389/fmed.2020.00248 PMC 바로가기 [Article Type] Medicine
[DOI] 10.3389/fmed.2020.00248 PMC 바로가기 [Article Type] Medicine
A Review: Does Complement or the Contact System Have a Role in Protection or Pathogenesis of COVID-19?
Review
[키워드] ACE2
acute respiratory distress
Angiotensin receptors
antagonists
anti-IL-6
antiviral therapy
approval
ARDS
benefit
bradykinin
complement
Contact
contact system
convalescent plasma
coronavirus
coronavirus pathogenesis
Corticosteroids
COVID-19
cytokine
Cytokine storm
death
defined
edema
effective
enzyme
etiology
Evidence
Human
Hydroxychloroquine
include
increase in
Intervention
investigated
knockout mice
less
Lung disease
manuscript
mice
mouse model
office
Pathogenesis
Pneumonia
Potential treatment
protection
Protective
Pulmonary edema
receptor
Result
risk
role
SARS-CoV
SARS-CoV-2
searched
syndrome
System
the disease
therapeutic intervention
Treatment
viruses
wild-type
[DOI] 10.1007/s41030-020-00118-5 PMC 바로가기 [Article Type] Review
[DOI] 10.1007/s41030-020-00118-5 PMC 바로가기 [Article Type] Review
Highlight of Immune Pathogenic Response and Hematopathologic Effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 Infection
Immunology
[키워드] acute respiratory distress
addition
ARDS
Care
caused
clinical trial
combined treatment
Complication
complications
coronavirus
Coronavirus infection
COVID-19
Cytokine storm
direct infection
Effect
global healthcare
global pandemic
Guidance
hematopathologic effect
Host immune response
immune
Immune cell
immune response
immune responses
immune therapy
infection mechanism
infection-induced lymphopenia
Invasion
killing
mechanism
medication
MERS-CoV
molecular mechanism
Novel coronavirus
outbreak
Patient
Potential treatment
Prevent
Prophylactic
pulmonary fibrosis
reduce
Replication
required
response
responses
resulting
risk
SARS-CoV
SARS-CoV-2
SARS-CoV-2 infected patient
Severe case
severe respiratory syndrome
Spread
syndrome
the disease
Therapeutic approach
therapeutic approaches
therapy
Vaccine
Vaccine development
Wuhan, China
[DOI] 10.3389/fimmu.2020.01022 PMC 바로가기 [Article Type] Immunology
[DOI] 10.3389/fimmu.2020.01022 PMC 바로가기 [Article Type] Immunology
COVID-19 in otolaryngologist practice: a review of current knowledge
Review Article
[키워드] Anosmia
Clinical characteristics
cough
COVID-19
COVID-19 cases
COVID-19 pandemic
COVID-19 patients
database
determine
develop
Diagnosis
disease transmission
Dizziness
dysfunction
Dyspnea
ear
ENT
individuals
infected with SARS-CoV-2
information
knowledge
limit
manifestation
mechanism
molecular
nasal congestion
nose and throat
Olfaction
Otolaryngological manifestations
otolaryngologist
Patient
Potential treatment
provide
Research
respiratory tract
Result
risk
SARS-CoV-2
searched
severe COVID-19
sore throat
surgeon
Symptom
symptoms of COVID-19
Travel
upper
URT
Web of Science
younger patient
[DOI] 10.1007/s00405-020-05968-y PMC 바로가기 [Article Type] Review Article
[DOI] 10.1007/s00405-020-05968-y PMC 바로가기 [Article Type] Review Article
In Silico Discovery of Candidate Drugs against Covid-19
Article
[키워드] ACE2
angiotensin converting enzyme
Aryldialkylphosphatase
atlas
bioinformatics
biosynthetic
candidate
Cell
cell receptor
co-expressed
correlated
COVID-19
dataset
Didanosine
drug
drugs
effective drug
evaluated
Evidence
Final
Flutamide
fluticasone
function
Gene Expression Omnibus
gene expression profile
gene network
Gene ontology
Genes
in silico
Infection
Interaction
investigated
lung
mechanism
nimesulide
Pathway enrichment analysis
Potential treatment
previous study
protein-protein interaction
provided
reported
SARS-CoV
SARS-CoV-2
Thiabendazole
Treatment
virus
[DOI] 10.3390/v12040404 PMC 바로가기 [Article Type] Article
[DOI] 10.3390/v12040404 PMC 바로가기 [Article Type] Article
A review of the safety of favipiravir – a potential treatment in the COVID-19 pandemic?
Review article
[키워드] 2019 coronavirus disease
adverse event
AEs
Analysis
Antiviral
Arm
ARMS
broad-spectrum antiviral
comparator
conducted
COVID-19
drug
Ebola
Effect
Elevation
Evidence
examined
Favipiravir
Follow-up
for inclusion
gastrointestinal AE
Human
indicated
Influenza
limitation
oseltamivir
pandemic
Participants
Placebo
Potential treatment
proportion
QTC prolongation
representing
repurposing
Result
Safe
safety profile
serious AE
serious AEs
shown
significantly
significantly more
Specific
statistical
teratogenicity
tolerable
Treatment
Trial
umifenovir
uric acid
widespread
[DOI] 10.1016/S2055-6640(20)30016-9 [Article Type] Review article
[DOI] 10.1016/S2055-6640(20)30016-9 [Article Type] Review article